AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Continente #
AS - Asia 6.327
NA - Nord America 2.237
EU - Europa 977
SA - Sud America 182
AF - Africa 39
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.772
Nazione #
SG - Singapore 5.032
US - Stati Uniti d'America 2.143
CN - Cina 659
IT - Italia 423
HK - Hong Kong 271
GB - Regno Unito 154
BR - Brasile 140
BD - Bangladesh 112
FR - Francia 107
DE - Germania 85
VN - Vietnam 84
FI - Finlandia 49
CA - Canada 45
NL - Olanda 45
IN - India 40
MX - Messico 36
TR - Turchia 25
ID - Indonesia 18
PL - Polonia 17
ES - Italia 16
AR - Argentina 15
ZA - Sudafrica 13
JP - Giappone 12
UA - Ucraina 12
RU - Federazione Russa 11
CZ - Repubblica Ceca 10
LT - Lituania 10
PK - Pakistan 10
AU - Australia 8
EC - Ecuador 8
IQ - Iraq 8
SA - Arabia Saudita 8
MY - Malesia 7
AT - Austria 6
PH - Filippine 6
JO - Giordania 5
PE - Perù 5
SE - Svezia 5
MA - Marocco 4
TN - Tunisia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
JM - Giamaica 3
KH - Cambogia 3
MD - Moldavia 3
OM - Oman 3
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
HN - Honduras 2
HT - Haiti 2
HU - Ungheria 2
KE - Kenya 2
LB - Libano 2
PY - Paraguay 2
TL - Timor Orientale 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BJ - Benin 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
RW - Ruanda 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 9.767
Città #
San Jose 645
Singapore 444
Ashburn 425
Dallas 272
Hong Kong 266
Rome 261
Hefei 206
Beijing 185
London 123
Boardman 116
Lauterbourg 85
Shanghai 73
Santa Clara 61
Council Bluffs 59
Munich 56
Los Angeles 42
West Jordan 40
Ho Chi Minh City 36
Amsterdam 34
Turku 26
New York 25
Washington 24
Helsinki 23
San Francisco 23
Mexico City 21
São Paulo 21
Sona 20
Seattle 19
Toronto 17
Bari 16
Warsaw 15
Ankara 14
Pune 12
Atlanta 11
Brooklyn 11
Brno 10
Changsha 10
Hanoi 10
Tokyo 10
Charlotte 9
Orem 9
Boston 8
Chennai 8
Manchester 8
Milan 7
Montreal 7
Phoenix 6
Rio de Janeiro 6
Buffalo 5
Chengdu 5
Chicago 5
Frankfurt am Main 5
Haiphong 5
Johannesburg 5
Lahore 5
Las Vegas 5
Naples 5
Paris 5
Amman 4
Belo Horizonte 4
Brasília 4
Da Nang 4
Denver 4
Duino-Aurisina 4
Haikou 4
Kuala Lumpur 4
Mumbai 4
Noicattaro 4
Nuremberg 4
Pasadena 4
Philadelphia 4
Ribeirão Preto 4
State College 4
Baghdad 3
Bologna 3
Brescia 3
Brest 3
Casablanca 3
Guangzhou 3
Guayaquil 3
Guiyang 3
Hải Dương 3
Lima 3
Manila 3
Muscat 3
New Delhi 3
Ninh Bình 3
Phnom Penh 3
Redmond 3
Sacramento 3
Secaucus 3
Stockholm 3
Sydney 3
Tashkent 3
The Dalles 3
Vienna 3
Vilnius 3
Wuhan 3
Arcore 2
Atibaia 2
Totale 4.024
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 247
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 241
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 231
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 231
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 229
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 228
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 226
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 223
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 216
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 209
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 208
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 206
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 200
Leptin in immuno-rheumatological diseases 190
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 177
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 140
Diabetes in chronic liver disease: from old concepts to new evidence 135
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 131
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 131
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 128
GH-resistance in different stages of chronic liver disease 128
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 125
Enhanced portal flow velocity and volume following Iloprost treatment 124
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 124
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 122
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 122
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 119
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 117
Radiofrequency ablation of hepatic tissue: a new experimental animal model 117
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 116
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 115
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 115
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 115
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 114
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 114
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 114
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 108
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 108
Pain and Frailty in Hospitalized Older Adults 107
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 103
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 102
Cannabinoids in Autoimmune and Rheumatic Diseases 102
ANA testing in ‘real life’ 101
Leptin in autoimmune mechanisms of systemic rheumatic diseases 101
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 95
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 91
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 90
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 89
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 85
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 82
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 75
TNF-alpha and growth hormone resistance in patients with chronic liver disease 68
The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study 66
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 64
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 64
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 60
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 59
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 58
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 57
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 57
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 57
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 57
Phase angle could be a marker of microvascular damage in systemic sclerosis 57
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 56
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 55
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 54
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 53
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 51
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 51
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 51
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 51
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 50
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 50
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 50
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 49
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 49
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 49
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 49
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 48
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 48
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 47
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 47
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 46
Surgical complications after resection of adrenal carcinoma 45
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 45
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 44
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 44
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 43
Matters of the heart: The case of TNF-alpha targeting drugs 43
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 43
Serum level of endostatin and digital ulcers in systemic sclerosis patients 42
Utility of ultrasound in the diagnosis of chronic worsened gout 41
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 41
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 41
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 41
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 40
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 39
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 39
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 39
Novel opportunities in automated classification of antinuclear antibodies on HEp-2 cells 38
Totale 9.703
Categoria #
all - tutte 53.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/20263.562 324 193 331 267 158 209 1.017 207 239 303 169 145
2026/202750 50 0 0 0 0 0 0 0 0 0 0 0
Totale 9.838